vimarsana.com
Home
Live Updates
Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD : vimarsana.com
Dr Martin Dahl Summarizes Findings, Limitations of Study Analyzing ANB032 Use in Patients With AD
Martin Dahl, PhD, of AnaptysBio discusses the findings and limitations of a study analyzing use of ANB032 in patients with atopic dermatitis (AD).
Related Keywords
United States ,
American ,
Martin Dahl ,
American Academy Of Dermatology ,
American Journal ,
Managed Care ,
American Academy ,
Dr Martin Dahl ,
Atopic Dermatitis ,
Aad ,
Interview ,
vimarsana.com © 2020. All Rights Reserved.